Acuren Corporation Ltd. Ordinary Shares TIC 深 沪
已收盘 10-17 16:00:00 美东时间
11.89
-0.390
-3.18%
华盛通- 最 高12.45
- 今 开12.15
- 成交量 355.53万股
- 最 低 11.89
- 昨 收 12.28
- 总市值 23.90亿
- 52周最高 14.9442
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 8.755
- 委 比 -60.00%
- 总股本 2.01亿
- 历史最高 14.9442
- 量 比 1.14
- 振 幅 4.56%
- 历史最低 8.755
- 每 手 1
- 风险率 1.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CITIC Telecom Renews Financial Services Agreements with CITIC Entities
CITIC Telecom International Holdings ( ($HK:1883) ) just unveiled an announceme...
10-17 17:42
V.F. Corporation (VFC) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Oct. 16, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to V.F. Corporation ("VFC" or the "Company") (NYSE: VFC) have opportu...
10-17 05:06
千觉机器人再获亿元PreA轮融资！上海具身智能基金领投，理想汽车等产业资本入局
近日，具身触觉头部企业千觉机器人（Xense Robotics）宣布完成亿元PreA轮融资，这是千觉今年内完成的第三轮。本轮融资由孚腾资本（上海具身智能基金...
10-16 09:31
FIRST INDUSTRIAL REALTY TRUST REPORTS THIRD QUARTER 2025 RESULTS
Signed 772,000 SF of New Leases for Development Projects in the Third Quarter and Fourth Quarter To-Date Remaining 501,000 SF at Building C at Our Camelback 303 JV in Phoenix in 3Q25 56,000 ...
10-16 04:31
美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元
今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元
10-13 11:26
珠澳地区首台！蔡司CALLISTO eye手术导航系统落户珠海希玛眼科医院
精准导航，清晰未来 近日，珠澳地区首台蔡司CALLISTO eye手术导航系统在珠海希玛林顺潮眼科医院正式落户开机。这标志着在数字化显微手术领域，珠海希玛眼科医...
10-11 12:02
German Economy Is In 'Free Fall' From Self-Inflicted Policies
Germany reported its steepest drop in industrial production in 3.7 years in Aug...
10-10 18:25
美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
UBS Maintains Neutral on Acuren, Raises Price Target to $15
UBS analyst Joshua Chan maintains Acuren (NYSE:TIC) with a Neutral and raises the price target from $11 to $15.
10-10 01:37
